{
    "data": [
        {
            "id": "4403513",
            "title": "Yamaha reports 9M results",
            "description": "<html><body><ul> <li>Yamaha <a href=\"https://www.yamaha.com/en/news_release/files/news/25020501/pdf/2502050101.pdf\" rel=\"nofollow\" target=\"_blank\">press release</a> (<a href=\"https://seekingalpha.com/symbol/YAMCF\" title=\"Yamaha Corporation\">OTCPK:YAMCF</a>): 9M revenue increased by ¥8.9 billion (+2.6%) year-on-year to ¥350.7 billion.</li> <li>Core operating profit increased by ¥4.1 billion (+14.9%) year on year to ¥31.9 billion, mainly due to the impact of the yen depreciation.</li> <li>For the<span class=\"paywall-full-content invisible\"> fiscal year ending March 31, 2025, the Company maintains its full-year revenue forecast of ¥460.0 billion.</span> </li> <li class=\"paywall-full-content invisible\">However, core operating profit has been revised downward from ¥37.0 billion (+9.9% year on year) to ¥33.0 billion (-1.9% year on year).</li> <li class=\"paywall-full-content invisible\">Profit for the period attributable to the owners of the parent has been revised downward from ¥18.0 billion (-39.3% year on year) to ¥13.5 billion (-54.5% year on year).</li> </ul> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4403513-yamaha-reports-9m-results",
            "pub_date": "2025-02-05 16:57:58",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4403504",
            "title": "KKR-backed Cotiviti close to deal to buy Edifecs for $3B - FT",
            "description": "<html><body><p>KKR-backed healthcare data firm Cotiviti is nearing a deal to acquire smaller rival Edifecs for more than $3 billion after deciding against a higher bid from UnitedHealth (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/UNH\" title=\"UnitedHealth Group Incorporated\">UNH</a></span>).</p> <p>UnitedHealth (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/UNH\" title=\"UnitedHealth Group Incorporated\">UNH</a></span>) offered $3.5 billion for Edifecs, though it was likely rejected in<span class=\"paywall-full-content invisible\"> favor of the lower bid from Cotiviti on the likelihood that a UNH deal may be challenged by antitrust regulators, according to a </span><a class=\"paywall-full-content invisible\" href=\"https://www.ft.com/content/26398eb5-3306-4512-a3ed-820f5d10d140\" rel=\"noopener\" target=\"_blank\" title=\"Financial Times repor\">Financial Times repor</a><span class=\"paywall-full-content invisible\">t on Wednesday, which cited people familiar with the matter. Cotiviti was also willing to move quicker than UNH to get a deal done. </span></p> <p class=\"paywall-full-content invisible\">Talks are ongoing, though a deal is near being finalized, according to the report. </p> <p class=\"paywall-full-content invisible\">Edifecs and KKR declined to comment to the FT. UnitedHealth didn't return requests for comment.</p> <p class=\"paywall-full-content invisible\">Edifecs decision to go with the lower offer comes after the Dept. of Justice<a href=\"https://seekingalpha.com/news/4391125-unitedhealth-amedisys-waive-right-to-end-merger\" rel=\"noopener\" target=\"_blank\" title=\" sued to block \"> sued to block </a> UnitedHealth's planned $3.3 billion purchase of home health and hospice provider Amedisys (<a href=\"https://seekingalpha.com/symbol/AMED\" title=\"Amedisys, Inc.\">AMED</a>) in November.</p> <p class=\"paywall-full-content invisible\"> </p> <p class=\"paywall-full-content invisible\"> </p> </body></html>",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2159946636/image_2159946636.jpg",
            "link": "https://seekingalpha.com/news/4403504-kkr-backed-cotiviti-close-to-deal-to-buy-edifecs-for-3b-ft",
            "pub_date": "2025-02-05 16:58:33",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4403511",
            "title": "American Assets Trust raises dividend by 1.5% to $0.340",
            "description": "<html><body><ul>\n<li>American Assets Trust (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/AAT\" title=\"American Assets Trust, Inc.\">AAT</a></span>) declares <a href=\"https://seekingalpha.com/pr/19991609-american-assets-trust-inc-reports-fourth-quarter-and-year-end-2024-financial-results\" target=\"_blank\">$0.340/share quarterly dividend</a>, <font color=\"green\">1.5% increase</font> from prior dividend of $0.335.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/AAT/dividends/yield?source=news_bullet\">Forward yield</a> 5.66%</li>\n<li>Payable March 20; for shareholders of record March 6; ex-div March 6.</li>\n<li><a href=\"https://seekingalpha.com/symbol/AAT/dividends?source=news_bullet\">See AAT Dividend Scorecard, Yield Chart, &amp; Dividend Growth.</a></li>\n</ul>\n</body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4403511-american-assets-trust-raises-dividend-by-15-to-0340",
            "pub_date": "2025-02-05 16:54:16",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4403509",
            "title": "USPS reverses track and says it will accept international inbound packages from China and Hong Kong",
            "description": "<html><body><p>The United States Postal Service announced on Wednesday that it continue accepting all international inbound mail and packages from China and Hong Kong Posts. The USPS said it is working closely with the Customs and Border Protection agency to implement an<span class=\"paywall-full-content invisible\"> efficient collection mechanism for the new China tariffs to ensure the least disruption to package delivery.</span></p> <p class=\"paywall-full-content invisible\">The announcement arrived just hours after the USPS had suspended service for the regions. The USPS decision does not impact the additional 10% tariff on Chinese goods or the closing of the \"de minimis\" trading loophole.</p> <p class=\"paywall-full-content invisible\">The de minimis trade exemption is a provision in U.S. trade law that allows packages valued under $800 to enter the U.S. duty-free and with minimal customs inspection. The exemption, which has been in place since the 1930s, has attracted significant attention lately due to its widespread use by e-commerce companies, particularly those based in China.</p> </body></html>",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1358927461/image_1358927461.jpg",
            "link": "https://seekingalpha.com/news/4403509-usps-reverses-track-and-says-it-will-accept-international-inbound-packages-from-china-and",
            "pub_date": "2025-02-05 16:54:56",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4403505",
            "title": "FMC downgraded at RBC Capital; shares plunge on weak outlook",
            "description": "<html><body><p class=\"MsoNormal\">FMC (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/FMC\" title=\"FMC Corporation\">FMC</a></span>) on Wednesday was downgraded to Sector Perform from a previous investment rating of Outperform by analyst at RBC Capital Markets. They said the maker of insecticides and other farming chemicals faces weak demand, as indicated on Tuesday in the<span class=\"paywall-full-content invisible\"> company’s quarterly earnings report.</span></p> <p class=\"MsoNormal paywall-full-content invisible\">Shares of FMC (<span class=\"ticker-hover-wrapper\">NYSE:<a href=\"https://seekingalpha.com/symbol/FMC\" title=\"FMC Corporation\">FMC</a></span>) plunged 25% in extended trading after disclosing fourth-quarter results.</p> <p class=\"MsoNormal paywall-full-content invisible\">“FMC (<a href=\"https://seekingalpha.com/symbol/FMC\" title=\"FMC Corporation\">FMC</a>) is working to lower inventory and introduce higher growth products, but we think the stock could be rangebound for the next several quarters,” Arun Viswanathan, analyst at RBC, said in a February 5 report. “FMC had previously indicated channel destocking was coming to an end, and we believe most investors were looking for mid-teens EBITDA growth next year on improving volumes and lower fixed costs.”</p> <p class=\"MsoNormal paywall-full-content invisible\">RBC cut its price target on FMC (<a href=\"https://seekingalpha.com/symbol/FMC\" title=\"FMC Corporation\">FMC</a>) to $47 a share from $78 a share previously, based on an estimated enterprise value that’s 10 times earnings before interest, taxes, depreciation and amortization for 2025.</p> <p class=\"MsoNormal paywall-full-content invisible\"> </p> </body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4403505-fmc-downgraded-at-rbc-capital-shares-plunge-on-weak-outlook",
            "pub_date": "2025-02-05 16:48:17",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4403506",
            "title": "Shimadzu reports 9M results",
            "description": "<html><body><ul>\n<li>Shimadzu <a href=\"https://www.shimadzu.com/sites/shimadzu.com/files/ir/wjav/fh0idk46aurdcwiz.pdf\" rel=\"nofollow\" target=\"_blank\">press release</a>  (<a href=\"https://seekingalpha.com/symbol/SHMZF\" title=\"Shimadzu Corporation\">OTCPK:SHMZF</a>): 9M Net Sales JPY 384.3B (+5.1% Y/Y). </li>\n<li>Basic Earnings per share JPY 122.94. </li>\n</ul>\n</body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4403506-shimadzu-reports-9m-results",
            "pub_date": "2025-02-05 16:48:37",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4403502",
            "title": "Golub Capital BDC declares $0.39 dividend",
            "description": "<html><body><ul>\n<li>Golub Capital BDC (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/GBDC\" title=\"Golub Capital BDC\">GBDC</a></span>) declares <a href=\"https://seekingalpha.com/pr/19991648-golub-capital-bdc-inc-announces-fiscal-year-2025-first-quarter-financial-results\" target=\"_blank\">$0.39/share quarterly dividend</a>, in line with previous.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/GBDC/dividends/yield?source=news_bullet\">Forward yield</a> 9.96%</li>\n<li>Payable March 28; for shareholders of record March 3; ex-div March 3.</li>\n<li><a href=\"https://seekingalpha.com/symbol/GBDC/dividends?source=news_bullet\">See GBDC Dividend Scorecard, Yield Chart, &amp; Dividend Growth.</a></li>\n</ul>\n</body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4403502-golub-capital-bdc-declares-0_39-dividend",
            "pub_date": "2025-02-05 16:44:00",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4403503",
            "title": "Adicet Bio receives FDA fast track designation for its lupus erythematosus treatment",
            "description": "<html><body><ul> <li>Adicet Bio (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/ACET\" title=\"Adicet Bio, Inc.\">ACET</a></span>) announced the U.S. Food and Drug Administration has granted Fast Track Designation to ADI-001 for the potential treatment of adult patients with refractory systemic lupus erythematosus with extrarenal involvement.</li>\n<li>ACET shares up about <font color=\"green\">11%</font> premarket.</li> <li>Source: <a href=\"https://seekingalpha.com/pr/19992113-adicet-bio-receives-fda-fast-track-designation-for-adiminus-001-for-the-treatment-of\">Press Release</a>\n</li>\n</ul>\n</body></html>",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1784925308/image_1784925308.jpg",
            "link": "https://seekingalpha.com/news/4403503-adicet-bio-receives-fda-fast-track-designation-for-its-lupus-erythematosus-treatment",
            "pub_date": "2025-02-05 16:44:21",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4403495",
            "title": "Giftify cancels equity line of credit",
            "description": "<html><body><ul> <li>Giftify (<span class=\"ticker-hover-wrapper\">NASDAQ:<a href=\"https://seekingalpha.com/symbol/GIFT\" title=\"Giftify, Inc.\">GIFT</a></span>), the owner and operator of leading digital platforms, CardCash.com and Restaurant.com, has announced the cancellation of its <a href=\"https://seekingalpha.com/pr/19992360-giftify-inc-cancels-equity-line-of-credit\">equity line of credit</a>.</li> <li>On Dec. 16, 2024, the Co. entered into a common stock purchase agreement with an institutional investor.</li>\n<li>Pursuant to the SPA, the Co. had the right, but not the obligation, to sell to the Investor, up to $10M of newly issued shares of the Co.’s common stock, subject to certain limitations and conditions.</li>\n<li>The Co. has exercised its right to terminate the SPA effective Feb. 4, 2025, by mutual agreement of the parties.</li>\n</ul></body></html>",
            "image": null,
            "link": "https://seekingalpha.com/news/4403495-giftify-cancels-equity-line-of-credit",
            "pub_date": "2025-02-05 16:38:55",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "4403479",
            "title": "U.S. Treasury offering $125B of securities in quarterly refunding",
            "description": "<html><body><p>The U.S. Treasury is offering $125B of Treasury securities to refund ~$106.2B of privately held Treasury notes and bonds maturing on Feb. 15, 2025, it said in a statement on Wednesday. The issuance will raise new cash from private investors of ~$18.8B.</p> <p class=\"paywall-full-content invisible\">The securities are:</p> <ul class=\"paywall-full-content invisible\"> <li>A three-year note in the amount of $58B, maturing Feb. 15, 2028 to be auctioned on Feb. 11;</li> <li>A 10-year note in the amount of $42B, maturing Feb. 15, 2035 to be auctioned on Feb. 12; and</li> <li>A 30-year bond in the amount of $25B, maturing Feb. 15, 2055 to be auctioned on Feb. 13.</li> </ul> <p class=\"paywall-full-content invisible\">In morning trading, the U.S. 10-year Treasury yield (<a href=\"https://seekingalpha.com/symbol/US10Y\" title=\"United States 10-Year Bond Yield\">US10Y</a>) fell 5 basis points to 4.46%.</p> <p class=\"paywall-full-content invisible\">Based on its current projected borrowing needs, the Treasury anticipates maintaining nominal coupon and floating rate note auction sizes for at least the next several quarters, it <a href=\"https://home.treasury.gov/news/press-releases/sb0010\" rel=\"noopener\" target=\"_blank\" title=\"said.\">said.</a></p> </body></html>",
            "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/157419721/image_157419721.jpg",
            "link": "https://seekingalpha.com/news/4403479-u_s_-treasury-offering-125b-of-securities-in-quarterly-refunding",
            "pub_date": "2025-02-05 16:38:56",
            "source": "seekalpha",
            "kind": 1,
            "language": "en"
        }
    ]
}